CSE: HAVN
OTC: HAVLF
FRA: 5NP
Get Notified
Edit Content
Main Menu
CSE: HAVN
OTC: HAVLF
FRA: 5NP

biomedicine

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Leave a Comment / Education, Health & Performance, Psychedelics / By

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and …

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

University of Wyoming, CaaMTech Team Up to Study Psychedelics as Treatments for Addiction

Leave a Comment / Education, Health & Performance, Psychedelics / By

The University of Wyoming’s School of Pharmacy and CaaMTech, a Washington state-based company that engineers psychedelic drugs, recently formed a collaboration in which UW researchers will evaluate CaaMTech’s proprietary compounds in addiction models as well as aim to demonstrate their anti-addictive properties. Ana Clara Bobadilla, an assistant professor in the UW School of Pharmacy, will lead …

University of Wyoming, CaaMTech Team Up to Study Psychedelics as Treatments for Addiction Read More »